No Wires, No Limits: A Bold Leap in Cardiac Tech
'This groundbreaking dual-chamber leadless pacemaker will revolutionise care for our patients and significantly expand the number of people we can help,' said Dr Azlan, Senior Consultant Cardiologist and Clinical Director of Interventional Electrophysiology and Implantable Devices at IJN.
'By eliminating traditional wires (leads) and surgical pockets, the system reduces common complications such as infections, lead dislodgement, and vessel blockage.'
Designed for individuals with bradycardia (a slower-than-normal heart rate), AVEIR™ DR represents a significant leap in cardiac pacing. Unlike traditional pacemakers that rely on wires and are implanted under the skin, this system uses two tiny devices (each about one-tenth the size of a conventional pacemaker) implanted directly into the heart's right atrium and ventricle.
At the core of this advancement is Abbott's proprietary i2i™ (implant-to-implant) communication technology. This system uses high-frequency pulses conducted through the body's blood flow to synchronise the two pacemakers in real-time. It not only provides beat-to-beat coordination but also conserves battery life far more efficiently than Bluetooth® or radio frequency-based systems.
'This technology opens up new possibilities for patients with abnormal heart rhythms,' added Dr Azlan. 'It also allows real-time pacing analysis during implantation, enabling precise positioning and reducing procedural risks.'
At IJN, innovation is not just about adopting the latest medical devices—it's about improving patient outcomes. The successful use of the AVEIR™ DR system is a significant step forward for heart care in the region and further cements IJN's standing as a leader in cardiovascular medicine.
Cardiovascular disease continues to pose a serious challenge in Malaysia and across Southeast Asia. IJN's Chief Executive Officer, Prof. Datuk Sri Dr Mohamed Ezani Md Taib, emphasised the importance of early diagnosis, public awareness, and the integration of advanced medical solutions to achieve better patient outcomes.
Addressing media questions during a press conference, Dr Azlan addressed questions from the media about the long-term outcomes and potential limitations of the device. He noted that, based on over a decade of experience, the complication rate for leadless pacemakers remains very low—less than 1% in the short term and only slightly higher over the long term. The process of replacing the device when the battery is depleted is also simpler and safer, as there are no leads to remove.
As stated, the device is specifically intended for patients with confirmed slow or irregular heart rhythms, typically diagnosed through ECG or other monitoring tools. While pacemakers are not suitable for all heart rhythm disorders, IJN's team is committed to training doctors from across Malaysia and the region to expand access to this life-changing technology. Plans are also underway to collaborate with manufacturers on future innovations tailored to specific patient needs.
As with any new medical technology, cost remains a consideration. IJN is working to structure pricing that makes the device accessible to both public and private patients. The hospital's model of using private-sector revenue to subsidise public care will also help ensure broader access as the technology becomes more widely adopted.
As the world's first and only dual-chamber leadless pacemaker, the AVEIR™ DR represents a significant advancement in minimally invasive heart care. Its wire-free design reduces risks, enables quicker recovery, and allows for future upgrades—reflecting Abbott's vision to empower patients to live fuller, healthier lives. Related
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Sun
3 days ago
- The Sun
AweMed Series Sponsors Eczema Family Day 2025 to Support Singapore's Sensitive Skin Community
SINGAPORE - Media OutReach Newswire - 3 July 2025 - AweMed®, a skincare brand developed in collaboration with local dermatologists and paediatricians, sponsored the Eczema Family Day 2025—an annual event organised by Eczema Support Group Singapore (ESGS). The event was held on 12 April, where patients, caregivers, and healthcare professionals came together to share knowledge, foster connections, and support individuals living with eczema in Singapore. Deepening Community Engagement Through Sponsorship The brand's decision to sponsor the Eczema Family Day stems from its ongoing commitment to supporting individuals and engaging local communities with sensitive and eczema-prone skin. While the brand has been providing gentle, eczema-friendly skincare solutions for several years, this marks a new chapter in its efforts to connect directly with the eczema community. 'We've always provided support for eczema patients through our products, but we recognised the need to do more,' said a spokesperson for AweMed®. 'Increasing our visibility within the eczema community has been a long-standing goal. So, when we were approached by the main event organiser about sponsoring or participating in the annual Eczema Family Day, we were eager to get involved.' Awareness and Education on Daily Eczema Management AweMed® also invited Dr. Ellie Choi, a board-certified dermatologist at the National University Hospital, to speak at the event. Her talk, titled 'Eczema Care for All Ages: Managing It in Adults and Kids,' highlighted the chronic nature of eczema and emphasised the importance of consistent, day-to-day management. Dr. Choi also underscored the vital role that eczema support networks play in helping individuals navigate their journey. The brand's involvement also went beyond sponsorship. Team members were present to connect with attendees, offer product samples, and share practical tips on caring for sensitive and eczema-prone skin. A selected number of visitors were offered a free moisturiser for itchy skin, and all ESGS members received a 10% promotional code. Overall, the event provided a meaningful platform for AweMed® to engage directly with the community about their individual skincare concerns. Launch of a New Free Sample Initiative For those who were not present at Eczema Family Day or are not part of the ESGS, AweMed is continuing to offer free samples as part of a three-month initiative. This move is in response to a common concern expressed by many Family Day attendees—hesitation in trying new skincare due to the reactivity of their skin. As such, this initiative is designed to offer a safe, no-obligation way for users to experience the company's formulations firsthand, making its products more accessible to those newly discovering the AweMed® skincare line. This free samples programme is open to all, with no specific eligibility requirements. Samples will be distributed on a first-come, first-served basis while stocks last. Readers can also visit the brand's Instagram page for updates about an ongoing promotion. About AweMed® AweMed® is a Singapore-based skincare brand formulated specifically for sensitive and eczema-prone skin. Developed in collaboration with experienced dermatologists and paediatricians, their range includes targeted solutions such as an eczema spray for quick relief and a skin-sensitive body wash for gentle cleansing. With a commitment to safety, efficacy, and comfort, AweMed empowers individuals to 'Itch Less, Live Better, Feel Awesome.'
Malaysian Reserve
3 days ago
- Malaysian Reserve
ReCerf Receives its CE Mark, Advancing Access to Ceramic Hip Resurfacing Across Europe
LEATHERHEAD, England, July 3, 2025 /PRNewswire/ — MatOrtho® is proud to announce that the ReCerf® Hip Resurfacing Arthroplasty (HRA) has received its CE mark, confirming compliance with European safety and performance standards. This important milestone expands access to hip resurfacing, enabling wider availability across the UK, Europe and internationally where CE marking supports market access. 'This is more than a regulatory milestone. It represents two decades of focused effort to improve hip resurfacing through an advanced material,' said Mike Tuke, Founder of MatOrtho. 'That became a possibility with BIOLOX® delta and cooperation with CeramTec A.G. which led in stages to ReCerf – an all-ceramic resurfacing implant that is already delivering excellent results. We're proud to make this more widely available to specialist hip resurfacing surgeons, and patients who want to stay active.' ReCerf is the world's first commercially available ceramic HRA, first approved by Australia's Therapeutic Goods Administration in November 2024. Since its initial use in 2018, over 1,600 patients have received the device. Patient-reported outcomes are highly positive, and the revision rate remains very low up to six years. Made from BIOLOX® delta ceramic, ReCerf eliminates concerns historically associated with metal-on-metal bearings and preserves more of the patient's natural bone. For surgeons, it offers a familiar procedure underpinned by improved materials, and is supported by a company long recognised as the home of modern hip resurfacing. ReCerf's availability under CE marking is matched by a strong commitment to responsible adoption. MatOrtho supports structured education, careful patient selection, and ongoing clinical monitoring. A peer-led surgeon training programme is already in place to ensure safe and effective use. This achievement strengthens MatOrtho's strategic growth and reaffirms its leadership in pioneering orthopaedic solutions designed to restore normal joint function and support high level activity. For more information visit: About MatOrtho: MatOrtho (formerly Finsbury Orthopaedics) is a global leader in orthopaedic invention and innovation, committed to advancing joint replacement technologies that improve patient outcomes and set new clinical standards. Website: Photo – – View original content:
The Sun
3 days ago
- The Sun
Wonderhealth Launches Health Awareness Drive Focused on Preventive Care
SINGAPORE - Media OutReach Newswire - 3 July 2025 - Wonderhealth Screeners has announced the launch of a nationwide health awareness initiative aimed at encouraging preventive healthcare practices across Singapore. This initiative seeks to promote early detection and informed lifestyle choices through a series of community-focused workshops, on-site health talks, and easily accessible digital resources. As part of this campaign, Wonderhealth is rolling out a variety of digital educational resources that cover common health risks and preventive strategies. These include home-based health screenings for greater accessibility, allergy testing to support early lifestyle adjustments, and LucenceINSIGHT™ Cancer Screening—a non-invasive tool designed to support early cancer detection. The initiative also offers corporate health screening options to support workplace wellness programs. 'We believe preventive healthcare is an essential part of everyday wellness,' said Edmund Yeo from Wonderhealth. 'Through this campaign, we aim to empower individuals and organizations with the knowledge and tools needed to take charge of their health early.' The campaign aligns with Wonderhealth's ongoing commitment to community education and accessible healthcare services. By providing evidence-based resources and creating opportunities for meaningful dialogue, Wonderhealth aims to support Singaporeans in making proactive health decisions. To learn more about upcoming workshops and screening options, visit Wonderhealth Pte Ltd At Wonderhealth Screeners, we are transforming the delivery of health screenings and wellness services across Singapore. We believe in the power of preventive care, early detection, and education as the cornerstones of building a healthier community. Our mission is simple but powerful: to make healthcare accessible, convenient, and affordable for everyone—whether at home, in the workplace, or within the community. With tailored screening solutions, a trusted medical team, and active community involvement, Wonderhealth is dedicated to empowering wellness for all.
